Viewing Page 5 of 26 | Showing Results 41 - 50 of 260

HPV vaccination and risk of MS

February 25, 2015
As long as the cause of multiple sclerosis (MS) remains unknown, it will be tempting – for patients and doctors alike – to search for an explanation among events that occurred before the diagnosis. This approach, known from antiquity as post hoc, ergo propter hoc (after the fact, therefore because of the fact), though sometimes successful, can also be misleading. History of science in general, and multiple sclerosis in particular, is rife with such fallacies. It is important to remember then, that this approach is best thought of as “brainstorming”, generating potential leads, but (almost) never the definitive proof.

Sensory integration balance training in patients with multiple sclerosis

February 21, 2015

There is increasing evidence that impairment of the sensory system in multiple sclerosis contributes to balance and gait disorders. The majority of the disruption of sensation comes from spinal cord lesions. MS spinal lesions have a propensity to affect the posterior portion of the spinal cord. This involves the Posterior column-medial lemniscus pathway (PCML) (also known as the dorsal column-medial lemniscus pathway) that conveys localized sensations of fine touch, vibration, two-point discrimination, and proprioception (position sense) from the skin and joints. It transmits information from the body to the postcentral gyrus of the cerebral cortex (brain).

A recent research article, “Sensory integration balance training in patients with multiple sclerosis: A randomized, controlled trial”, highlights that rehabilitation targeted to this issue may help:

Swedish Health Services partners with Kindred Healthcare to deliver new TeleICU program

February 18, 2015

Kindred Hospital Seattle First Hill offers additional clinical monitoring and support for patients

SEATTLE – Feb. 18, 2015 – Starting today, Kindred Hospital Seattle First Hill will begin using Swedish’s TeleICU system to provide an additional layer of care and clinical monitoring for its patients.

Using two-way cameras and audio feeds, TeleICU allows remote care teams to conduct rounds, provide services and support ICU nurses. Special early-warning software collects information about blood pressure, heart rate, oxygen saturation, medication orders and X-rays to give the TeleICU teams vital information to monitor each patient's status closely, along with onsite caregivers. With the flip of a switch, the TeleICU team can communicate directly with the patient’s nurse and provide needed support. The TeleICU team typically includes an intensivist, registered nurses and support staff who monitor patients in multiple hospitals.

Join the Swedish MS Center Walk Team at Walk MS

February 17, 2015

The Swedish MS Center, Neuro-ophthalmic Consultants Northwest, and Seattle Radiologists have formed a team for Walk MS to experience a great event and help the National MS Society fund research, advocate for change, and help people with MS live their best lives.

Walk MS is a day that ...

Catch the Multiple Sclerosis Roadshow in Tacoma

February 14, 2015

Experts from the Multiple Sclerosis Center at Swedish Neuroscience Institute and the National Multiple Sclerosis Society are bringing Multiple Sclerosis (MS) education and information to Tacoma. Come learn from a nationally recognized team of MS health care professionals, share your experience, and connect with others in the community living with MS.

When: Saturday, March 28
Time: 9:30 a.m. – 1:45 p.m.
Where: LeMay America's Car Museum, 2702 East D Street, Tacoma 98421
Cost: Free

Seminar Topics:

Swedish celebrates twenty-two recipients of the DAISY award for extraordinary nursing

February 12, 2015

On Monday, Feb. 9, Swedish Medical Center honored twenty-two nurses who received the DAISY Award for Extraordinary Nurses, presented by The DAISY Foundation and UnitedHealthcare.

During a special ceremony, nurses received a certificate that read: “In deep appreciation of all you do, who you are, and the incredibly meaningful difference you make in the lives of so many people.”

February Pet of the Month at the Multiple Sclerosis Center

February 12, 2015

Cat: Kelly Bear
Owner: Misty
Age: 4
Breed: Domestic Longhair Calico
From: Eva's Eden - Cat Rescue, Blaine, Washington
Favorite toy: Toy bird that chirps
Favorite snack: Greenies treats
Unique fact: Only female cats can be Calico
Best trick: To walk on a leash or ride in a car
Describe your pet in one word: Love
How has your pet taught you to live life?
"She has shown unconditional love and taught me to  ...

Copaxone and the Interferon Betas Are Clinically Similar

February 10, 2015
Copaxone and the interferon betas (IFN-β) are both effective treatments for a relapsing form of multiple sclerosis (MS). A new study finds that MS patients followed over 10 years have similar annualized relapse rates (ARR) whether they take Copaxone or one of the interferon betas.

This recent study looked at 10 years of data on over 3,000 RRMS patients and found that Copaxone and IFN-β were similarly successful in reducing relapses. In the new study, researchers collected data on 3,326 RRMS patients who were using either IFN-β or Copaxone as their first-ever disease-modifying therapy (DMT) for at least 6 months, and had started treatment within 10 years of their first symptom. To be included in the study, patients also had to have had at least one relapse recorded during the two years leading up to the start of their initial DMT.

The researchers looked at ...

MS Patient Enjoys Skiing Again

February 07, 2015

Bud Feuerstein is flying down the mountainside on an adaptive mono ski, a product of Outdoors For All (a nonprofit organization that enables recreational activities for individuals with disabilities).



Eight years prior, Bud would have been carving the slopes on his own set of skis, but due to a rare disease, he was left paralyzed from the chest down. Bud will never forget the night he was lying in bed and an odd sensation came over his body. Within seconds, he was paralyzed. Months later, he was diagnosed with transverse myelitis, a disease in the multiple sclerosis family. Having a better chance of winning the lottery, Bud was blindsided by this diagnosis, and his life was forever changed.

With this earth-shattering news, Bud had two fears:

Preliminary results from study of myelin repair

February 06, 2015

Results were released recently from a study of a medication that may promote myelin repair. The MS Center at Swedish was one of the research sites for this study. The medication, rHIgM22, is an antibody that encouraged myelin repair in animal models. The way that it helps with myelin repair is not known. This study was a phase I study, which means that it was the first time that this medication was used in humans. Phase I studies are done to determine the safety of a medication, and also to help determine the dose of the medication.

In this study, patients ...